Filing Analysis
Cardlytics received a Nasdaq delisting notice due to the stock price remaining below $1.00 for 30 consecutive business days. To regain compliance, the company is implementing a 1-for-10 reverse stock split effective June 5, 2026.
🚩 Red Flags
- Delisting notice from Nasdaq
- Reverse stock split (typically a sign of extreme share price distress)
- Multiple 8-K items (3.01 and 3.03) in a single filing
- Significant reduction in authorized share capital
📋 Key Facts
- Received Nasdaq delisting notice on June 3, 2026, for violation of Rule 5550(a)(2) (minimum bid price of $1.00).
- Implementing a 1-for-10 reverse stock split effective June 5, 2026, at 5:00 p.m. ET.
- Authorized shares reduced from 100,000,000 to 10,000,000.
- Shares outstanding will decrease from 58,078,634 to approximately 5,807,863.
- Split-adjusted trading on Nasdaq begins June 8, 2026.
- New CUSIP number: 14161W303.
Cardlytics, Inc. (CDLX) held its Annual Meeting on May 20, 2026, at which stockholders approved four proposals. Most critically, stockholders approved a reverse stock split authorization giving the Board discretion to execute a 1-for-5 to 1-for-15 reverse split of common stock at any time prior to the 2027 Annual Meeting. This strongly signals potential Nasdaq compliance concerns given the wide split ratio range authorized.
🚩 Red Flags
- Reverse stock split authorization with a very wide ratio range (1-for-5 to 1-for-15) suggests significant stock price distress and likely Nasdaq minimum bid price non-compliance ($1.00 minimum)
- Upper end of split ratio (1-for-15) implies current stock price could be as low as $0.07-$0.20/share range to bring it back to a compliant level, indicating severe price deterioration
- Board granted sole discretion to act at any time through 2027 Annual Meeting, creating prolonged uncertainty for shareholders
- Say-on-pay vote was relatively weak: 9,840,538 For vs. 3,379,898 Against (~74.4% approval), suggesting shareholder dissatisfaction with executive compensation
- Significant withhold votes against Jack Klinck (2,008,136) and Shrishti Gupta (2,016,667), nearly 15% of non-broker votes — possible governance concerns
- Deloitte & Touche retention as auditor amid what appears to be a distressed stock situation warrants monitoring
📋 Key Facts
- Annual Meeting held May 20, 2026; 34,996,216 of 55,070,709 shares (63.54%) represented
- Proposal 3 APPROVED: Reverse stock split authorized at Board's discretion, ratio ranging from 1-for-5 to 1-for-15, inclusive, effective any time prior to 2027 Annual Meeting
- Reverse split vote: 32,745,480 For vs. 2,205,871 Against (93.7% approval among voting shares)
- Corresponding proportionate reduction in total authorized shares approved alongside the reverse split
- Board retains sole discretion on timing, exact ratio selection (1-for-5 through 1-for-15), or full abandonment
- Proposal 1 APPROVED: Three Class II directors elected — Amit Gupta (12.7M for), Jack Klinck (11.3M for), Shrishti Gupta (11.3M for) — to serve until 2029
- Proposal 2 APPROVED: Deloitte & Touche LLP ratified as auditor for fiscal year ending December 31, 2026 (34,494,578 For vs. 404,398 Against)
- Proposal 4 APPROVED (advisory): Named executive officer compensation approved with 9,840,538 For vs. 3,379,898 Against — notably weak approval (~74.4% of non-broker votes)
- 21,725,998 broker non-votes on director election and say-on-pay proposals
- Filing signed by David Evans, Chief Financial Officer
Nick Lynton, the Chief Legal and Privacy Officer of Cardlytics, Inc., has resigned effective July 3, 2026, or upon the appointment of a successor. The company has entered into a Transition Agreement providing for a severance package and an advisory role during the transition period.
📋 Key Facts
- Nick Lynton notified the company of his resignation on May 10, 2026.
- The resignation is effective July 3, 2026, or earlier if a successor is appointed.
- Lynton will receive a lump sum separation payment of $380,000.
- The company will provide COBRA premium reimbursement for up to 12 months.
- An additional lump sum payment of $70,320.21 is scheduled for payment in Q1 2027.
- The Transition Agreement replaces a previous Separation Pay Agreement dated August 8, 2022.
Cardlytics, Inc. announced its financial results for the first quarter ended March 31, 2026, and scheduled a conference call to discuss performance.
📋 Key Facts
- Financial results for the quarter ended March 31, 2026, were released on May 7, 2026.
- The announcement includes a press release (Exhibit 99.1).
- The filing is signed by CFO David Evans.
- The disclosure is made under Item 2.02 (Results of Operations and Financial Condition).
Cardlytics, Inc. completed the sale of its Bridg platform assets to PAR Technology Corporation on March 24, 2026. The consideration for the sale consisted of 1,810,222 shares of PAR common stock.
🚩 Red Flags
- Divestiture of a major technology platform (Bridg) may indicate a significant shift in business strategy or a need to simplify operations.
- The consideration is entirely in PAR common stock, exposing Cardlytics to the market volatility of a single external security.
📋 Key Facts
- Closing date of the Bridg Sale was March 24, 2026.
- The buyer is DB Sub, LLC, an indirect wholly owned subsidiary of PAR Technology Corporation.
- Cardlytics received 1,810,222 shares of PAR common stock as consideration.
- The assets sold include all properties and rights primarily related to the Bridg platform.
- The filing includes pro forma financial statements for the years ended December 31, 2023, 2024, and 2025 to reflect the impact of the disposition.
Cardlytics, Inc. reported its financial results for the fourth quarter and fiscal year ended December 31, 2025. The company furnished a press release and announced a conference call to discuss these results.
📋 Key Facts
- The filing was made on March 4, 2026, to report results for the period ended December 31, 2025.
- The report was filed under Item 2.02 (Results of Operations and Financial Condition).
- A press release containing the financial details was furnished as Exhibit 99.1.
- The company scheduled a conference call to discuss corporate highlights and financial performance.